EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrated network pharmacology and experimental validation for identification of mechanism of icariin targeting PLK1 in inhibiting hepatocellular carcinoma

Zhang Wei, Ma Fenglian, Sun Xiangjun

Digital Chinese Medicine · 2026-03 · 9 (1) · 130-143

DOI: 10.1016/j.dcmed.2026.02.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digital Chinese Medicine, 2026-03. Verfasst von Zhang Wei und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wei, Z., Fenglian, M., & Xiangjun, S. (2026). Integrated network pharmacology and experimental validation for identification of mechanism of icariin targeting PLK1 in inhibiting hepatocellular carcinoma. Digital Chinese Medicine, 9(1), 130-143. https://doi.org/10.1016/j.dcmed.2026.02.012

Vancouver

Wei Z, Fenglian M, Xiangjun S. Integrated network pharmacology and experimental validation for identification of mechanism of icariin targeting PLK1 in inhibiting hepatocellular carcinoma. Digital Chinese Medicine. 2026;9(1):130-143. doi:10.1016/j.dcmed.2026.02.012

BibTeX
@article{Wei2026,
  author = {Wei, Zhang and Fenglian, Ma and Xiangjun, Sun},
  title = {Integrated network pharmacology and experimental validation for identification of mechanism of icariin targeting PLK1 in inhibiting hepatocellular carcinoma},
  journal = {Digital Chinese Medicine},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {130--143},
  doi = {10.1016/j.dcmed.2026.02.012}
}
Kostenlos starten →